Earnings History Data for ImmunoGen, Inc. (IMGN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ImmunoGen, Inc.

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
02-11-2023	PM		IMGN	ImmunoGen, Inc.	3,700	0.10	0.02	-0.31	ImmunoGen GAAP EPS of $0.10 beats by $0.06, revenue of $113.4M beats by $8.19M [11/2/2023 6:31 AM]	15.50	0.56 (3.75%)	15.50	0.0 (0.00%)	3.61 - 20.69	13,092,864	7,600,000	72,300
ImmunoGen Q3 2023 Earnings Preview [11/1/2023 12:52 PM] ImmunoGen GAAP EPS of $0.10 beats by $0.06, revenue of $113.4M beats by $8.19M [11/2/2023 6:31 AM] ImmunoGen stock gains 7% amid Q3 report, positive study results [11/2/2023 12:43 PM]
31-07-2023	PM		IMGN	ImmunoGen, Inc.	4,170	-0.02	-0.16	-0.24	ImmunoGen GAAP EPS of -$0.02 beats by $0.12, revenue of $83.15M beats by $36.55M [7/31/2023 6:31 AM]	17.80	-1.72 (-8.84%)	19.45	-0.07 (-0.36%)	3.61 - 20.69	12,475,444	4,120,000	527,828
ImmunoGen GAAP EPS of -$0.02 beats by $0.12, revenue of $83.15M beats by $36.55M [7/31/2023 6:31 AM] ImmunoGen medical chief steps down [7/31/2023 6:55 AM]
28-04-2023	PM	6:30 AM ET (Apr 28)	IMGN	ImmunoGen, Inc.	958.44	-0.16	-0.25	-0.10	ImmunoGen GAAP EPS of -$0.16 beats by $0.09, revenue of $49.87M [4/28/2023 6:36 AM]	5.38	1.06 (24.65%)	5.23	0.91 (21.06%)	3.10 - 6.63	16,575,110	3,050,000	495,329
ImmunoGen Q1 2023 Earnings Preview [4/27/2023 11:00 AM] ImmunoGen GAAP EPS of -$0.16 beats by $0.09, revenue of $49.87M [4/28/2023 6:36 AM] ImmunoGen surges 22% on Q1 earnings beat [4/28/2023 11:12 AM]
01-03-2023	PM	6:30 AM ET (Mar 1)	IMGN	ImmunoGen, Inc.	871.97	-0.23	-0.29	-0.17	ImmunoGen beats Q4 top and bottom line estimates; initiates FY23 outlook [3/1/2023 6:32 AM]	4.02	0.14 (3.61%)	4.00	0.12 (3.09%)	3.10 - 6.63	7,134,454	4,450,000	79,927
ImmunoGen Q4 2022 Earnings Preview [2/28/2023 1:00 PM] ImmunoGen beats Q4 top and bottom line estimates; initiates FY23 outlook [3/1/2023 6:32 AM] Vertex in pact with ImmunoGen to expand gene editing reach [3/1/2023 6:56 AM]
04-11-2022	PM	6:30 AM ET (Nov 4)	IMGN	ImmunoGen, Inc.	1,210	-0.31	-0.26	-0.18	ImmunoGen reports Q3 mixed earnings; raises FY22 revenue guidance [11/4/2022 6:33 AM]	5.55	-0.12 (-2.12%)	5.79	0.12 (2.12%)	3.10 - 7.77	1,874,036	3,570,000	2,077
ImmunoGen Q3 2022 Earnings Preview [11/3/2022 2:09 PM] ImmunoGen reports Q3 mixed earnings; raises FY22 revenue guidance [11/4/2022 6:33 AM] ImmunoGen Reports Recent Progress and Third Quarter 2022 Financial Results [Nov-04-22 06:30AM] Should You Buy ImmunoGen (IMGN) Ahead of Earnings? [Nov-03-22 08:48AM]
29-07-2022	PM	6:30 AM ET (Jul 29)	IMGN	ImmunoGen, Inc.	1,090	-0.24	-0.22	-0.15	ImmunoGen GAAP EPS of -$0.24 misses by $0.03, revenue of $14.2M misses by $1.98M, reiterates FY guidance [7/29/2022 6:34 AM]	4.74	-0.51 (-9.71%)	4.93	-0.32 (-6.10%)	3.10 - 7.77	3,436,734	2,570,000	6,033
ImmunoGen Q2 Earnings Preview [7/28/2022 12:42 PM] ImmunoGen GAAP EPS of -$0.24 misses by $0.03, revenue of $14.2M misses by $1.98M, reiterates FY guidance [7/29/2022 6:34 AM] ImmunoGen stock down 7% on disappointing Q2 result [7/29/2022 11:36 AM] ImmunoGen Reports Recent Progress and Second Quarter 2022 Financial Results [Jul-29-22 06:30AM]
06-05-2022	PM	6:30 AM ET (May 6)	IMGN	ImmunoGen, Inc.	1,140	-0.10	-0.21	-0.17	ImmunoGen GAAP EPS of -$0.10 beats by $0.11, revenue of $38.08M beats by $17.24M [5/6/2022 6:32 AM]	4.63	-0.22 (-4.54%)	4.63	0.0 (0.00%)	3.83 - 7.77	4,193,747	2,740,000	2,271
ImmunoGen Q1 2022 Earnings Preview [5/5/2022 11:30 AM] ImmunoGen GAAP EPS of -$0.10 beats by $0.11, revenue of $38.08M beats by $17.24M [5/6/2022 6:32 AM] ImmunoGen Reports Recent Progress and First Quarter 2022 Financial Results [May-06-22 06:30AM] ImmunoGen (IMGN) Reports Q1 Loss, Tops Revenue Estimates [May-06-22 07:45AM] ImmunoGen (IMGN) Q1 2022 Earnings Call Transcript [May-06-22 01:30PM]
25-02-2022	PM	6:30 AM ET (Feb 25)	IMGN	ImmunoGen, Inc.	1,100	-0.17	-0.18	0.16	ImmunoGen GAAP EPS of -$0.17 beats by $0.01, revenue of $28M beats by $2.07M [2/25/2022 6:31 AM]	5.38	0.27 (5.19%)	5.11	0.0 (0.00%)	4.58 - 9.62	2,608,904	3,140,000	300
ImmunoGen Q4 2021 Earnings Preview [2/24/2022 11:35 AM] ImmunoGen GAAP EPS of -$0.17 beats by $0.01, revenue of $28M beats by $2.07M [2/25/2022 6:31 AM] ImmunoGen Reports Recent Progress and 2021 Financial Results [Feb-25-22 06:30AM] ImmunoGen (IMGN) Reports Q4 Loss, Tops Revenue Estimates [Feb-25-22 07:45AM]
29-10-2021	PM	6:30 AM ET (Oct 29)	IMGN	ImmunoGen, Inc.	1,180	-0.18	-0.19	-0.13	ImmunoGen EPS in-line, misses on revenue [10/29/2021 6:30 AM]	6.05	0.13 (2.11%)	5.85	-0.07 (-1.18%)	4.97 - 10.88	2,427,026	1,220,000	2,539
ImmunoGen Q3 2021 Earnings Preview [10/28/2021 1:18 PM] ImmunoGen EPS in-line, misses on revenue [10/29/2021 6:30 AM] Immunogen eyes ovarian cancer pivotal trial data release this quarter, BLA in Q1 2022 [10/29/2021 8:14 AM] ImmunoGen Reports Recent Progress and Third Quarter 2021 Financial Results [Oct-29-21 06:30AM] ImmunoGen (IMGN) Reports Q3 Loss, Misses Revenue Estimates [Oct-29-21 07:45AM] ImmunoGen, inc (IMGN) Q3 2021 Earnings Call Transcript [Oct-29-21 05:00PM]
30-07-2021	PM	6:30 AM ET (Jul 30)	IMGN	ImmunoGen, Inc.	1,130	-0.15	-0.18	-0.14	ImmunoGen EPS beats by $0.03, misses on revenue [7/30/2021 6:36 AM]	5.61	-0.04 (-0.80%)	5.50	-0.15 (-2.65%)	3.38 - 10.88	1,080,575	1,130,000	1,892
ImmunoGen Q2 2021 Earnings Preview [7/29/2021 1:50 PM] ImmunoGen EPS beats by $0.03, misses on revenue [7/30/2021 6:36 AM] ImmunoGen posts wider Q2 net loss as R&D expenses ramp [7/30/2021 7:50 AM] ImmunoGen Reports Recent Progress and Second Quarter 2021 Financial Results [Jul-30-21 06:30AM] ImmunoGen (IMGN) Reports Q2 Loss, Misses Revenue Estimates [Jul-30-21 07:55AM] ImmunoGen, inc (IMGN) Q2 2021 Earnings Call Transcript [Jul-30-21 11:30AM]
10-05-2021	PM	6:30 AM ET (May 10)	IMGN	ImmunoGen, Inc.	1,420	-0.17	-0.19	-0.17	ImmunoGen EPS beats by $0.02, misses on revenue; reaffirms guidance [5/10/2021 6:33 AM]	6.51	-0.82 (-11.14%)	7.14	-0.19 (-2.59%)	3.38 - 10.88	2,048,633	1,650,000	556
ImmunoGen EPS beats by $0.02, misses on revenue; reaffirms guidance [5/10/2021 6:33 AM] ImmunoGen shares fall after Q1 topline miss, FY forecast [5/10/2021 8:01 AM] ImmunoGen, Inc. to Host Earnings Call [May-10-21 06:15AM] ImmunoGen Reports Recent Progress and First Quarter 2021 Financial Results [May-10-21 06:30AM] ImmunoGen (IMGN) Reports Q1 Loss, Misses Revenue Estimates [May-10-21 07:45AM] Immunogen Inc (IMGN) Q1 2021 Earnings Call Transcript [May-10-21 12:00PM] ImmunoGen (IMGN) Q1 Earnings Top, Pivotal Studies Delayed [May-10-21 11:03AM]
12-02-2021	PM	6:30 AM ET (Feb 12)	IMGN	ImmunoGen, Inc.	1,530	0.16	-0.04	0.03	ImmunoGen EPS beats by $0.24, beats on revenue [2/12/2021 6:33 AM]	10.49	2.41 (29.83%)	8.58	0.50 (6.19%)	1.95 - 10.88	16,946,037	1,665,128	111,778
ImmunoGen EPS beats by $0.24, beats on revenue [2/12/2021 6:33 AM] ImmunoGen shares rise on strong Q4 topline, 2021 forecast [2/12/2021 8:00 AM] ImmunoGen (IMGN) Surpasses Q4 Earnings and Revenue Estimates [Feb-12-21 07:45AM] ImmunoGen Reports Recent Progress and 2020 Financial Results [Feb-12-21 06:30AM] ImmunoGen, Inc. to Host Earnings Call [Feb-12-21 06:15AM] Earnings Scheduled For February 12, 2021 [Feb-12-21 04:37AM] ImmunoGen Announces Webcast of Presentation at Upcoming SVB Leerink 10th Annual Global Healthcare Conference [Feb-11-21 04:30PM] Earnings Preview: Immunogen [Feb-11-21 10:04AM]
06-11-2020	PM	6:30 AM ET (Nov 6)	IMGN	ImmunoGen, Inc.	1,130	-0.13	-0.20	-0.15	ImmunoGen EPS beats by $0.06, beats on revenue [11/6/2020 6:35 AM]	6.08	0.03 (0.50%)	6.05	0.0 (0.00%)	1.95 - 7.07	5,027,496	1,983,794	4,363

31-07-2020	PM	6:30 AM ET (Jul 31)	IMGN	ImmunoGen, Inc.	725.53	-0.14	-0.18	-0.29	ImmunoGen EPS beats by $0.03, beats on revenue [7/31/2020 6:31 AM]	4.14	-0.22 (-5.15%)	4.41	0.04 (0.92%)	1.95 - 7.07	1,868,009	2,171,998	23,333